n CME : Your SA Journal of CPD - Pharm info




Extracted from text ... PHARM INFO Groundbreaking diabetes study offers head-to-head comparison of Avandia, metformin and glibenclamide The prevalence of diabetes worldwide has been estimated at 135 million people in 1995 and is projected to increase to 300 million by 2025.This global trend not only has profound medical ramifications, but also social and economic consequences because of the costs of managing diabetes and treating secondary complications of the disease. To date a limited number of long-term studies have compared the impact of different therapies on the progression of type 2 diabetes. The United Kingdom Prospective Diabetes Study (UKPDS), for example, demonstrated that treatment ..


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error